Stockscreener 앱 받기
0.7309
0.42%
-0.0031
전일 마감가:
$0.734
열려 있는:
$0.7392
하루 거래량:
4,688
Relative Volume:
0.04
시가총액:
$30.54M
수익:
$13.42M
순이익/손실:
$-73.35M
주가수익비율:
-0.3807
EPS:
-1.92
순현금흐름:
$-56.34M
1주 성능:
-7.48%
1개월 성능:
-34.74%
6개월 성능:
-26.17%
1년 성능:
-21.41%
1일 변동 폭
$0.7306
$0.748
1주일 범위
$0.7001
$0.8187
52주 변동 폭
$0.64
$2.92
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Company Profile
명칭
Barinthus Biotherapeutics Plc Adr
전화
44 (0) 1865 818808
주소
20400 CENTURY BLVD, GERMANTOWN
BRNS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BRNS
Barinthus Biotherapeutics Plc Adr
|
0.748 | 29.44M | 13.42M | -73.35M | -56.34M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.99 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
721.27 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.47 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
897.98 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.61 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-05-25 | 개시 | Jefferies | Buy |
| 2021-05-25 | 개시 | Morgan Stanley | Overweight |
| 2021-05-25 | 개시 | William Blair | Outperform |
| 2021-05-24 | 개시 | H.C. Wainwright | Buy |
Barinthus Biotherapeutics Plc Adr 주식(BRNS)의 최신 뉴스
Halper Sadeh LLC Encourages HFWA, BRNS, FITB Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
HC Wainwright Has Optimistic View of BRNS FY2025 Earnings - Defense World
Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights - Finviz
Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights - Barchart.com
Barinthus Biotherapeutics Plc. ADR (BRNS) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Barinthus Biotherapeutics PLC Sponsored ADR (NASDAQ:BRNS) Short Interest Update - MarketBeat
Barinthus Biotherapeutics (BRNS) to Release Earnings on Wednesday - MarketBeat
Heidmar Maritime Holdings Corp (HMR): What Does Valuation Ratios Tell Us? - fostersleader.com
Insider Activity Monitoring: Ysx Tech Co.Ltd (YSXT) - fostersleader.com
A Peek At What Barinthus Biotherapeutics Plc. ADR (BRNS) Insiders Are Doing - fostersleader.com
Linkers Industries Ltd (LNKS) Stock: Should Investors Follow These Insider Trades? - fostersleader.com
Dogwood Therapeutics Inc (DWTX): Keep paying attention to its insider activity - fostersleader.com
Check Out Insider Trades For Hawkins Inc (HWKN) Stock - fostersleader.com
How Have Insiders Been Trading Grupo Aeroportuario Del Pacifico SAB de CV ADR (PAC) Stock? - fostersleader.com
Stock on Demand This Week: RCI Hospitality Holdings Inc (RICK) - fostersleader.com
How Does Wall Street Rate Shares Of Inventiva ADR (IVA)? - fostersleader.com
Is Buying Stock In Whitehawk Therapeutics Inc (WHWK) A Good Move Today? - fostersleader.com
Marti Technologies Inc (MRT): What is the Risk Factor? - fostersleader.com
Quest Resource Holding Corp (QRHC): Technicals Say You should Hold - fostersleader.com
What is Bright Minds Biosciences Inc (DRUG) Price Targets? - fostersleader.com
Alexander’s Inc (ALX): What Does Valuation Ratios Tell Us? - fostersleader.com
Operating cash flow per share of Barinthus Biotherapeutics plc Sponsored ADR – DUS:2AB - TradingView
ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics - Barchart.com
Barinthus Biotherapeutics (NASDAQ:BRNS) Shares Down 6.3%Should You Sell? - MarketBeat
Operating cash flow per share of Barinthus Biotherapeutics plc Sponsored ADR – GETTEX:2AB - TradingView
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders - Barchart.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (NasdaqETNB), Barinthus Biotherapeutics plc (NasdaqBRNS), Verint Systems Inc. (Nasdaq - GlobeNewswire Inc.
Barinthus Biotherapeutics (NASDAQ:BRNS) Earns Sell (D-) Rating from Weiss Ratings - Defense World
Is Buying Stock In Radiopharm Theranostics Ltd ADR (RADX) A Good Move Today? - fostersleader.com
Cartesian Therapeutics Inc (RNAC): What Does Valuation Ratios Tell Us? - fostersleader.com
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ETNB, TRML, CORZ, BRNS on Behalf of Shareholders - Barchart.com
BARINTHUS BIOTHERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plcBRNS - The Globe and Mail
Morning Market Movers: DBVT, CLPT, DWTX, Seeing Big Swings - RTTNews
Holdings of FTAI Infrastructure Inc (FIP) are aligned with the stars - Setenews
Barinthus Biotherapeutics (NASDAQ:BRNS) Shares Down 15.5% – Here’s Why - Defense World
Short Interest in Barinthus Biotherapeutics PLC Sponsored ADR (NASDAQ:BRNS) Grows By 498.5% - MarketBeat
BRNS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Barinthus Biotherapeutics plc Is Fair to Shareholders - The Globe and Mail
Barinthus Bio and Clywedog to merge in all-stock deal - Investing.com
37,450 Shares in Barinthus Biotherapeutics PLC Sponsored ADR $BRNS Acquired by HighTower Advisors LLC - Defense World
Raymond James Financial Inc. Raises Stock Position in Virtus Terranova U.S. Quality Momentum ETF $JOET - Defense World
Freehold Royalties (TSE:FRU) Stock Price Crosses Above Two Hundred Day Moving Average – What’s Next? - Defense World
Colombia Energy Resources (OTCMKTS:CERX) Stock Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
PNC Financial Services Group Inc. Increases Stake in United Microelectronics Corporation (NYSE:UMC) - Defense World
BRNS’s Market Whiplash: 50.99% YTD Rise, 152.41% Rise in 30 Days - investchronicle.com
BRNS stock touches 52-week low at $0.8 amid market volatility - Investing.com
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Strong Buy: Here's Why - Nasdaq
Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com
Mexico Shingles Vaccine Market Size & Outlook, 2025-2030 - Grand View Research
What is the current Price Target and Forecast for Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) - Zacks Investment Research
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Investing.com UK
Barinthus Biotherapeutics plc Share Price ADR Each Rep 1 Ord Share Spon - Hargreaves Lansdown
Barinthus Biotherapeutics Plc Adr (BRNS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.82%
1.03%
자본화:
|
볼륨(24시간):